Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MCHR1 | Q99705 | 9/20 | 0.51 |
| ▸ | ATF4 | P18848 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ADIPOR2 | Q86V24 | 1/20 | 0.46 |
| ▸ | ADIPOR1 | Q96A54 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2987366 | 0.95 | MCHR1 (0.54) | POLBMCHR1ATF4EPHX2SMN1; SMN2 | |
| SCHEMBL2987178 | 0.94 | ATF4 (0.58) | POLBMCHR1ATF4EPHX2SMN1; SMN2 | |
| SCHEMBL2978691 | 0.90 | MCHR1 (0.51) | POLBMCHR1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL2981330 | 0.89 | POLB (0.51) | POLBSMN1; SMN2CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL2987483 | 0.89 | ATF4 (0.61) | POLBMCHR1ATF4SMN1; SMN2USP2 | |
| SCHEMBL2982908 | 0.89 | MCHR1 (0.50) | POLBMCHR1ATF4SIGMAR1SMN1; SMN2 | |
| SCHEMBL2987754 | 0.88 | POLB (0.50) | POLBSIGMAR1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL2987025 | 0.88 | SIGMAR1 (0.47) | MCHR1SIGMAR1EPHX2 | |
| SCHEMBL5162540 | 0.88 | MCHR1 (0.46) | POLBMCHR1SIGMAR1 | |
| SCHEMBL2981298 | 0.87 | ATF4 (0.56) | POLBMCHR1ATF4SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7786328-B2 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2010-08-31 | — | — | US | claimed |
| JP-2007536322-A | — | — | 2007-12-13 | — | — | JP | claimed |
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2007-12-06 | — | — | US | claimed |
| EP-1747191-A1 | SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES WITH A CHAIN EXTENSION | Grünenthal GmbH (DE) | 2007-01-31 | — | — | EP | claimed |
| WO-2005110975-A1 | SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES WITH A CHAIN EXTENSION | Grünenthal GmbH (DE) | 2005-11-24 | — | — | WO | claimed |
| US-7786328-B2 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2010-08-31 | — | — | US | disclosed |
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | DPYD, PKD1, AOC1 | POLB 1844/4885MCHR1 1826/4885ATF4 1845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.